MALAISE is the #5 most commonly reported adverse reaction for NICOTINE POLACRILEX, manufactured by Haleon US Holdings LLC. There are 1,499 FDA adverse event reports linking NICOTINE POLACRILEX to MALAISE. This represents approximately 2.4% of all 62,946 adverse event reports for this drug.
NICOTINE POLACRILEX has an overall safety score of 78 out of 100. Patients taking NICOTINE POLACRILEX who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE1,499 of 62,946 reports
MALAISE is a less commonly reported adverse event for NICOTINE POLACRILEX, but still significant enough to appear in the safety profile.
Other Side Effects of NICOTINE POLACRILEX
In addition to malaise, the following adverse reactions have been reported for NICOTINE POLACRILEX:
MALAISE has been reported as an adverse event in 1,499 FDA reports for NICOTINE POLACRILEX. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with NICOTINE POLACRILEX?
MALAISE accounts for approximately 2.4% of all adverse event reports for NICOTINE POLACRILEX, making it a notable side effect.
What should I do if I experience MALAISE while taking NICOTINE POLACRILEX?
If you experience malaise while taking NICOTINE POLACRILEX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.